참고문헌
- Boddu SK, Aurangabadkar G, Kuchay MS. New onset diabetes, type 1 diabetes and COVID-19. Diab Metab Synd 2020;14:2211-7. https://doi.org/10.1016/j.dsx.2020.11.012
- DiMeglio LA. COVID-19 and type 1 diabetes: addressing concerns and maintaining control. Diabetes Care 2021;44:1924-8. https://doi.org/10.2337/dci21-0002
- Dayal D, Gupta S, Raithatha D, Jayashree M. Missing during COVID-19 lockdown: children with onset of type 1 diabetes. Acta Paediatr 2020;109:2144-6. https://doi.org/10.1111/apa.15443
- d'Annunzio G, Maffeis C, Cherubini V, Rabbone I, Scaramuzza A, Schiaffini R, et al. Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia. Diabetes Res Clin Pract 2020;168:108372. https://doi.org/10.1016/j.diabres.2020.108372
- Thakur N, Rai N. Diabetic ketoacidosis in children induced by coronavirus disease 2019 (COVID-19) diabetic ketoacidosis post-COVID-19 in children. Clin Exp Pediatr 2021 Nov 30. https://doi.org/10.3345/cep.2021.00941. [Epub].
- Unsworth R, Wallace S, Oliver NS, Yeung S, Kshirsagar A, Naidu H, et al. New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K. Diabetes Care 2020;43:e170-1. https://doi.org/10.2337/dc20-1551
- Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol 2010;47:193-9. https://doi.org/10.1007/s00592-009-0109-4
- Hoffmann M, Kleine-Weber H, Schroeder S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020;181:271-80. https://doi.org/10.1016/j.cell.2020.02.052
- Egloff C, Vauloup-Fellous C, Picone O, Mandelbrot L, Roques P. Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2. J Clin Virol 2020;128:104447. https://doi.org/10.1016/j.jcv.2020.104447